Careers

The ADRI is a state-of-the-art research facility promoting an environment of innovation, collaboration and research excellence in asbestos-related diseases.

Current Positions

Unfortunately there are currently no positions available at ADRI. Please check back with us periodically.

Postgraduate Studies

Australia has the world's highest incidence of malignant mesothelioma per capita, with more than 600 new cases diagnosed each year, and it has been estimated that there were at least another 1,500 Australians with lung cancer caused by asbestos. This is a tragic consequence of the intensive use of asbestos and its products in Australia in the previous century and is estimated that as many as one in three homes in Australia contains asbestos. As a response to this legacy, the Asbestos Diseases Research Institute (ADRI) was opened in 2009 and is a state-of- the- art medical research facility dedicated to the prevention and treatment of asbestos-related diseases, particularly asbestos-related lung cancer and malignant mesothelioma.

Under the leadership of Professor Ken Takahashi, ADRI’s research framework focuses on:

  1. Fundamental Biology Research;
  2. Clinical Sciences; and
  3. Public Health and Prevention (including themes on epidemiology and QOL studies).

We are currently seeking high calibre students to pursue PhD or Masters studies in asbestos-related diseases research.

How To Apply

All applications are to be submitted to Professor Takahashi for consideration info@adri.org.au. As ADRI is a not-for-profit medical research organisation, it is unlikely that a research program will have the funds to take on a postgraduate student without scholarship funding. However, there are over 700 scholarship schemes on offer, visit The University of Sydney’s Scholarships Office for further information.

Projects Available

  1. Prevention of Asbestos-Related Diseases
  2. To discover biomarkers that better facilitate early diagnosis of mesothelioma
  3. Pre-clinical anti-mesothelioma discovery

Meet Our Students

Mr Tom Johnson

Mr Tom Johnson

PhD Fellow
Tom started as a summer student at ADRI in 2015. He is now doing his PhD and his project will follow on from preliminary data conducted at ADRI which suggests YB-1 is involved in the drug resistance of malignant pleural mesothelioma (MPM) cell lines. It will further the understanding of chemo-resistance in this disease and therefore has the potential to improve MPM patient outcome in the development of future drugs. Tom was awarded a PhD scholarship by ADFA to support his studies at The University of Sydney.
Ms Marissa Williams

Ms Marissa Williams

PhD Fellow
Marissa commenced work at ADRI in February 2012 as a research assistant, and began her PhD studies in 2015. Marissa has a Bachelor of Forensic Biology in Biomedical Science from UTS (2010) and a Bachelor Science (Hons) (2011) in a project on paediatric oncology at the Tumour bank, Westmead Children’s Hospital. This project was based on drug resistance mechanisms of a childhood cancer to novel therapeutics. In her PhD studies, Marissa is investigating the mechanisms driving microRNA downregulation in malignant pleural mesothelioma and their involvement in drug resistance. Marissa was awarded a PhD scholarship by Sydney Catalyst to support her studies at The University of Sydney. Marissa was awarded a Young Investigator Award by the International Association for the Study of Lung Cancer (IASLC) at the 18th IASLC World Conference on Lung Cancer in Yokohama, Japan in October 2017 for her presentation entitled: “Multiple mechanisms contribute to downregulation of tumour suppressor microRNAs in malignant pleural mesothelioma”.
Mr Kadir Sarun

Mr Kadir Sarun

Research Assistant
Kadir has Bachelor of Forensic Biology in Biomedical Science from UTS (2015) and is currently completing a Master’s of Science (Research) degree. Kadir was awarded the Young Investigator Award by the International Association for the Study of Lung Cancer (IASLC) and the Local Organising Committee of the 17th IASLC World Conference on Lung Cancer (WCLC) which was presented at the IASLC Business Meeting in Vienna on the 6th December 2016. He was also awarded a Concord Repatriation General Hospital Research Travel Scholarship.
Mr Patrick Winata

Mr Patrick Winata

Masters Student
Patrick has a Bachelor of Science with First Class Honours from UTS (2015). Patrick worked at ADRI for 6 months as a Research Assistant on a number of projects. Patrick is focusing his research project on noncoding RNAs (ncRNAs) as biomarkers and therapeutic targets for malignant pleural mesothelioma (MPM). Patrick is completing his Masters through The University of Sydney.